Medicare drug price negotiations reduce total U.S. drug spending by 8%

If Trump’s reforms pass, Medicare begins direct negotiations with drug manufacturers by 2027, leading to an 8% reduction in total U.S. prescription drug spending within two years. Savings are realized through lower prices and increased generic competition.

Implied probability (Yes)

60%